Three years after Covid, this is Big Pharma’s new playground. RSV (respiratory syncytial virus), which causes bronchiolitis, already has three vaccines approved in recent weeks in Europe and the United States. Shipments have started in some countries.
Last year, the influenza-bronchiolitis-Covid triple pandemic brought health systems to their knees, barely recovering from a two-year health crisis. Bronchiolitis, which particularly affects infants and the elderly, was particularly severe. “It is rare to see a new market opening up in the pharmaceutical industry. says Vincent Meunier, industry specialist at Bryan, Garnier & Co. Against RSV, we went from nothingness to a battle of giants“.
Until then, there was only one treatment for severe forms, AstraZeneca’s Synagis. Six decades of research have ended in failure. Worldwide, RSV annually causes…
Source: Le Figaro
I am John Sinkler, a professional writer and journalist for Buna Times. I specialize in writing about entertainment-related topics and have been doing so for several years now. My work has been featured on multiple platforms and I’m proud to say that it’s gained recognition from many people in the industry. Aside from working at Buna Times, I also write freelance articles for other publications.